Q3 2023 · 13F-HR
DEERFIELD MANAGEMENT COMPANY, L.P.holdings as filed
Filed 2023-11-14 · accession 0000950159-23-000305
$4.54B
Reported value
88
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670703107 | NUVL | NUVALENT INC | $919.0M | 20.2% | 19,991,024 | Common | SOLE |
| 377322AB8 | GKOS 2.75 06/15/27 | GLAUKOS CORP | $426.5M | 9.40% | 271,452,000 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $195.9M | 4.32% | 19,863,485 | Common | SOLE |
| 46185LAH6 | — | INVITAE CORP | $163.8M | 3.61% | 217,766,000 | Common | SOLE |
| 873379AA9 | — | TABULA RASA HEALTHCARE INC | $141.5M | 3.12% | 144,516,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $137.1M | 3.02% | 1,990,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $136.1M | 3.00% | 1,209,714 | Common | SOLE |
| 632307AB0 | NTRA 2.25 05/01/27 | NATERA INC | $133.5M | 2.94% | 101,042,000 | Common | SOLE |
| 00653Q102 | AHCO | ADAPTHEALTH CORP | $123.8M | 2.73% | 13,607,940 | Common | SOLE |
| 112463AC8 | BKD 2 10/15/26 | BROOKDALE SR LIVING INC | $114.3M | 2.52% | 145,955,000 | Common | SOLE |
| 00437EAB8 | — | ACCOLADE INC | $107.9M | 2.38% | 132,598,000 | Common | SOLE |
| 457669AA7 | — | INSMED INC | $107.6M | 2.37% | 108,858,000 | Common | SOLE |
| 45845PAC2 | — | INTERCEPT PHARMACEUTICALS IN | $105.1M | 2.32% | 98,354,000 | Common | SOLE |
| 690732102 | ACH | OWENS & MINOR INC NEW | $104.0M | 2.29% | 6,435,000 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $95.8M | 2.11% | 8,192,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $91.4M | 2.01% | 3,876,938 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $87.7M | 1.93% | 6,897,606 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $66.9M | 1.47% | 16,941,357 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $62.4M | 1.37% | 173,947 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $61.2M | 1.35% | 2,268,628 | Common | SOLE |
| 29332G102 | EHABUSD | ENHABIT INC | $56.2M | 1.24% | 4,997,746 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $53.9M | 1.19% | 4,004,231 | Common | SOLE |
| 63009RAD1 | — | NANOSTRING TECHNOLOGIES INC | $53.0M | 1.17% | 70,204,000 | Common | SOLE |
| 112463104 | BKD | BROOKDALE SR LIVING INC | $52.5M | 1.16% | 12,679,651 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $48.5M | 1.07% | 1,751,496 | Common | SOLE |
| 539183AA1 | TDOC 0.875 06/01/25 | LIVONGO HEALTH INC | $45.7M | 1.01% | 50,000,000 | Common | SOLE |
| 457985208 | IART | INTEGRA LIFESCIENCES HLDGS C | $43.0M | 0.95% | 1,126,827 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $42.7M | 0.94% | 1,460,000 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $41.9M | 0.92% | 11,077,927 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $39.9M | 0.88% | 4,374,044 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $39.4M | 0.87% | 1,329,935 | Common | SOLE |
| 45845P108 | — | INTERCEPT PHARMACEUTICALS IN | $38.5M | 0.85% | 2,077,893 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $36.5M | 0.80% | 1,579,574 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $35.6M | 0.78% | 2,340,118 | Common | SOLE |
| 14171W103 | — | CAREMAX INC | $33.7M | 0.74% | 15,873,213 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $31.7M | 0.70% | 627,813 | Common | SOLE |
| 42225TAB3 | — | HEALTH CATALYST INC | $28.5M | 0.63% | 30,000,000 | Common | SOLE |
| 75525N107 | — | RAYZEBIO INC | $25.7M | 0.57% | 1,159,126 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $25.4M | 0.56% | 4,764,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $23.3M | 0.51% | 3,286,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $22.5M | 0.50% | 3,933,137 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $20.3M | 0.45% | 127,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $20.2M | 0.45% | 430,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $19.1M | 0.42% | 2,747,015 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $18.7M | 0.41% | 1,604,487 | Common | SOLE |
| 69366JAD3 | PTCT 1.5 09/15/26 | PTC THERAPEUTICS INC | $17.5M | 0.39% | 22,000,000 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $16.7M | 0.37% | 3,500,000 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $16.0M | 0.35% | 946,620 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $15.6M | 0.34% | 1,269,992 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $14.2M | 0.31% | 1,279,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $13.4M | 0.30% | 754,042 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $12.5M | 0.28% | 1,538,461 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $12.3M | 0.27% | 594,989 | Common | SOLE |
| 219798105 | QDEL | QUIDELORTHO CORP | $11.0M | 0.24% | 150,000 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $10.6M | 0.23% | 1,089,345 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $10.5M | 0.23% | 1,017,958 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $10.0M | 0.22% | 870,000 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $9.8M | 0.22% | 1,827,400 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $9.0M | 0.20% | 448,753 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $8.9M | 0.20% | 793,729 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $8.4M | 0.19% | 885,314 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $8.3M | 0.18% | 650,000 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $7.9M | 0.17% | 723,000 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $7.3M | 0.16% | 2,823,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $6.8M | 0.15% | 1,055,192 | Common | SOLE |
| 64049MAA8 | — | NEOGENOMICS INC | $6.0M | 0.13% | 6,500,000 | Common | SOLE |
| 68236X100 | TOI | THE ONCOLOGY INSTITUTE INC | $4.7M | 0.10% | 3,360,052 | Common | SOLE |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $4.6M | 0.10% | 1,253,895 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $3.9M | 0.09% | 777,525 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $2.8M | 0.06% | 400,256 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $2.7M | 0.06% | 930,447 | Common | SOLE |
| 68570P200 | — | ORCHARD THERAPEUTICS PLC | $2.4M | 0.05% | 316,169 | Common | SOLE |
| 82933R100 | — | SINGULAR GENOMICS SYSTEMS IN | $1.9M | 0.04% | 4,984,871 | Common | SOLE |
| 005111109 | AFIB | ACUTUS MED INC | $1.9M | 0.04% | 2,660,808 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.4M | 0.03% | 583,913 | Common | SOLE |
| 232109108 | CUTREUR | CUTERA INC | $929,524 | 0.02% | 154,406 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $176,295 | 0.00% | 92,787 | Common | SOLE |
| 14171W111 | — | CAREMAX INC | $134,400 | 0.00% | 672,000 | Common | SOLE |
| 89680M119 | TLSIW | TRISALUS LIFE SCIENCES INC | $126,667 | 0.00% | 333,333 | Common | SOLE |
| 68236X118 | TOIIW | THE ONCOLOGY INSTITUTE INC | $114,875 | 0.00% | 1,250,000 | Common | SOLE |
| 58406B202 | MDVLQ | MEDAVAIL HOLDINGS INC | $100,392 | 0.00% | 16,732 | Common | SOLE |
| 74765K113 | QSIAW | QUANTUM SI INC | $90,000 | 0.00% | 333,333 | Common | SOLE |
| 124155110 | BFLYW | BUTTERFLY NETWORK INC | $48,547 | 0.00% | 733,333 | Common | SOLE |
| 82621J204 | S0Z0 | SIENTRA INC | $27,800 | 0.00% | 10,000 | Common | SOLE |
| 83444K113 | — | SOMALOGIC INC | $26,412 | 0.00% | 120,000 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $16,667 | 0.00% | 166,666 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $6,850 | 0.00% | 166,666 | Common | SOLE |
| 89680M101 | TLSI | TRISALUS LIFE SCIENCES INC | $5 | 0.00% | 1 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.